Guardant Health to present 20 liquid-biopsy abstracts at 2026 lung cancer conference

Verifying
  • Guardant Health and collaborators will present 20 abstracts at the 2026 conference.
  • 20 abstracts will highlight liquid biopsy tests for early detection and treatment management.
  • The presentations are scheduled for the 2026 World Conference on Lung Cancer.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.